Specialty Pharma Journal Specialty, Precision & Technology
CHARLOTTE, N.C.–(BUSINESS WIRE)–Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, has agreed to acquire the national specialty pharmacy business of Lincare Holdings Inc., headquartered in Clearwater, Fla. The $75 million acquisition includes Acro Pharmaceutical Services LLC and Community Pharmacy Services, LLC. Premier expects to fund the transaction with available …
Tag Archives: Premier Inc.
June, 2016
November, 2015
-
3 November
Who’s Teaching Whom in the World of Biosimilars? The Rise of Patient Education
By Kathleen P. Wolff, MBA Specialty Pharma Journal As consumers begin to adapt to the high cost of biologic medicines and their biosimilar counterparts, there may be a shift in education, with patients – not providers – leading the way. The concept was posed at the Biosimilars 20/20 conference this summer …
September, 2015
-
9 September
Biosimilars’ Success in the US: Will Physicians Rule the Road?
By Kathleen P. Wolff, MBA Specialty Pharma Journal As the high cost of new biologic medicines sends U.S. healthcare costs soaring, payers are anxiously anticipating the introduction of biosimilar medicines – biological products, approved by FDA because they are highly similar to an already FDA-approved biological product. However, there is one …